| FDMLX | VMVAX | FDMLX / VMVAX | |
| Total Expense Ratio | 0.00 | 0.07 | - |
| Annual Report Gross Expense Ratio | 0.00 | 0.07 | - |
| Fund Existence | 13 years | 14 years | - |
| Gain YTD | 3.857 | 4.224 | 91% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.84B | 33.2B | 9% |
| Annual Yield % from dividends | 2.59 | 2.10 | 124% |
| Returns for 1 year | 5.63 | 13.84 | 41% |
| Returns for 3 years | -1.99 | 30.76 | -6% |
| Returns for 5 years | -36.81 | 51.40 | -72% |
| Returns for 10 years | 1.45 | 142.26 | 1% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| KCSIX | 13.84 | 0.06 | +0.44% |
| Knights of Columbus Small Cap I | |||
| MSDMX | 17.11 | 0.04 | +0.23% |
| Morgan Stanley Emerging Mkt ex China R6 | |||
| FTAWX | 14.47 | N/A | N/A |
| Fidelity Advisor Asset Manager 20% A | |||
| HRCCX | 32.46 | -0.42 | -1.28% |
| Carillon ClariVest Capital Apprec C | |||
| CVGRX | 47.08 | -0.70 | -1.47% |
| Calamos Growth A | |||